secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2023-05-09T23:59:59+00:00
Accession:  0001104659-23-057817
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PowerUp Acquisition enters additional Non-Redemption Agreements covering 750,000 shares for extension vote
--------------------------------------------------------------------------------

- Five additional Non-Redemption Agreements with unaffiliated third parties covering 750,000 Class A ordinary shares.
- Sponsor to transfer 375,000 Class B ordinary shares to investors post-business combination if shares held through meeting.
- Agreements increase funds remaining in trust after extraordinary general meeting to approve extension to May 23, 2024.
- Total non-redeemed shares now 900,000 (previous 150,000 + 750,000) under all Non-Redemption Agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000110465923057817/0001104659-23-057817-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000110465923057817/tm2315181d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-057817

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer